PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BD Issues 2011 Sustainability Report - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the publication of its 2011 Sustainability Report - BD.com
BD Issues 2011 Sustainability Report

 

NewswireToday - /newswire/ - Franklin Lakes, NJ, United States, 2012/05/23 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the publication of its 2011 Sustainability Report - BD.com. NYSE: BDX

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The report focuses on the Company’s shared-value approach to sustainability, which focuses on the relationship among strong economic performance, social responsibility and respect for the environment.

"We are pleased to report on BD’s progress in achieving our sustainability goals, as well as how we are addressing the many challenges we face in the global business environment," said Vincent A. Forlenza, Chief Executive Officer and President. "We are broadening and redefining our approach to products, markets, services, productivity and even associate engagement, to drive higher shared value as well as higher shareholder value.”

This year, BD’s reporting aligns more closely with version 3.1 of the Global Reporting Initiative (GRI) guidelines, and the Company has self-assessed the new report at GRI application level B. BD’s 2011 Sustainability Report highlights strategic priorities and performance in areas including:

• Governance and Ethics: BD remains committed to ethical operations and compliance with laws and regulations. In 2011, the Company updated its Code of Conduct and initiated Project Compass, the rollout of its enhanced global anti-corruption and anti-bribery program.
• Product Responsibility: BD addresses social and environmental concerns in areas including product quality, patient and healthcare worker safety, and product stewardship from development to disposal. In 2011, the Company added a sustainability assessment to its Global Product Development System, inaugurated Procurement Sustainability Summits for suppliers, and became a member of the Environmentally Preferable Purchasing Business Leadership Coalition, which is part of the Practice Greenhealth Greening the Supply Chain™initiative.
• The Environment: BD continued to make progress toward meeting its 2015 Sustainability Targets, including reducing energy consumption 3.2% absolute and 13.2% normalized (against a goal of reducing 30% normalized by 2015) and reducing greenhouse gas emissions 21.6% absolute through a combination of energy conservation and purchase of renewable energy credits. Additionally, three BD locations received LEED Gold certification in 2011.
• Society: BD deploys its core competencies, expertise, products and associates in an effort to improve global health standards and access to health for all. The Company develops and implements collaborative, cross-sector programs with governments, international agencies, nonprofit organizations and research institutions, focusing on areas that align societal needs with BD’s business strategy.
• Associates: The success of BD's business depends on the creativity, innovation and commitment of the 29,000 people it employs in more than 50 countries around the world. The report highlightsBD’s focus on health and safety in the workplace, providing learning and development opportunities, building a diverse workforce and creating an inclusive culture.

The new report also highlights the many awards and recognitions that BD received in 2011 in the areas of sustainability, innovation, employer of choice, and environment, health and safety, including:

• Dow Jones Sustainability World and North America Indexes
• 2011 Green Rankings Top 100 (Newsweek)
• "World's Most Ethical Companies"(Ethisphere Council)
• U.S. EPA Green Power Partnership Member – 2011 Leadership Club
• CEO Cancer Gold Standard™ Accreditation
• Best Employers for Healthy Lifestyles (U.S. National Business Group on Health).

To view the full BD 2011 Sustainability Report online, visit bd.com/sustainability.

About BD
BD (bd.com), a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

Contact:
Monique N. Dolecki, Investor Relations
P: (201) 847-5378 - E: monique_dolecki[.]bd.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Becton, Dickinson and Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BD Issues 2011 Sustainability Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

BD |
Publisher Contact: Colleen T. White - BD.com 
201-847-5369 colleen_white[.]bd.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Becton, Dickinson and Company / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Persistence Market Research (P) Ltd

Visit RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)